SECURITY AGREEMENTSecurity Agreement • August 10th, 2023 • Ayala Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS SECURITY AGREEMENT (this “Agreement” or this “Security Agreement”), dated August 7, 2023, by and between AYALA PHARMACEUTICALS, INC., a Delaware corporation, with headquarters located at 9 Deer Park Drive, Suite K-1, Monmouth Junction, New Jersey 08852 (the “Debtor”), and ISRAEL BIOTECH FUND I, L.P. (the “Secured Party”).
SENIOR SECURED CONVERTIBLE PROMISSORY NOTESenior Secured Note Agreement • August 10th, 2023 • Ayala Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS SENIOR SECURED CONVERTIBLE PROMISSORY NOTE is the duly authorized and validly issued convertible promissory note of AYALA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), having its principal place of business at 9 Deer Park Drive, Suite K-1, Monmouth Junction, New Jersey 08852, designated as its Senior Secured Convertible Promissory Note due August 7, 2028 (the “Note” or this “Note”).
